Understanding Thalidomide Therapy
Thalidomide is an oral immunomodulatory drug that is widely used throughout the myeloma disease course in the frontline, consolidation/maintenance, and relapse settings. Immunomodulatory drugs induce immune responses, enhance the activity of immune cells, and inhibit inflammation by altering the levels of various growth factor.